One new case of Coronavirus has been confirmed in Abuja FCT, Nigeria. The Nigerian Centre for Disease Control (NCDC) announced this on her official twitter handle @NCDCgov on Sunday morning.
One new case of #COVID19 has been confirmed in FCT, Nigeria
As at 11:00 am on the 22nd of March, there are 27 confirmed cases of #COVID19 in Nigeria
Of the 27 confirmed cases, 2 have been discharged with no death pic.twitter.com/Taxi37NzjW
— NCDC (@NCDCgov) March 22, 2020
This brings the total figure of confirmed cases in Nigeria to 27.
Of the 27 confirmed cases, 19 are in Lagos state, 4 in Abuja FCT, 2 in Ogun state, 1 in Ekiti and Oyo states respectively.
Two have fully recovered and been discharged, including the Italian index case. No death has been recorded in Nigeria so far.
COVID-19 Update in Nigeria
On the 28th of November 2020, 110 new confirmed cases were recorded in Nigeria
The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increases as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 67,330 confirmed cases.
On the 28th of November 2020, 110 new confirmed cases were recorded in Nigeria, having carried out a total daily test of 7,101 samples across the country.
To date, 67,330 cases have been confirmed, 62,819 cases have been discharged and 1,171 deaths have been recorded in 36 states and the Federal Capital Territory. A total of 756,237 tests have been carried out as of November 28th, 2020 compared to 749,136 tests a day earlier.
COVID-19 Case Updates- 28th November 2020,
- Total Number of Cases – 67,220
- Total Number Discharged – 62,686
- Total Deaths – 1,171
- Total Tests Carried out – 756,237
According to the NCDC, the 110 new cases were reported from 11 states- Lagos (26), FCT (23), Kaduna (20), Katsina (11), Ogun (7), Ekiti (6), Plateau (5), Rivers (4) Kano (3), Nasarawa (3) and Niger (2).
Meanwhile, the latest numbers bring Lagos state total confirmed cases to 23,190, followed by Abuja (6,767), Plateau (3,857), Oyo (3,721), Kaduna (3,064), Rivers (2,977), Edo (2,696), Ogun (2,222), Delta (1,824), Kano (1,794), Ondo (1,728), Enugu (1,332), Kwara (1,096), Ebonyi (1,055), Katsina (1,025), Osun (945), Gombe (938). Abia (926), Bauchi (770), and Borno (745).
Imo State has recorded 662 cases, Benue (496), Nasarawa (491), Bayelsa (445), Ekiti (365), Akwa Ibom (339), Jigawa (331), Niger (298), Anambra (285), Adamawa (261), Sokoto (165), Taraba (159), Yobe (94), Kebbi (93), Cross River (90), Zamfara (79), while Kogi state has recorded 5 cases only.
Lock Down and Curfew
In a move to combat the spread of the pandemic disease, President Muhammadu Buhari directed the cessation of all movements in Lagos and the FCT for an initial period of 14 days, which took effect from 11 pm on Monday, 30th March 2020.
The movement restriction, which was extended by another two weeks period, has been partially put on hold with some businesses commencing operations from May 4. On April 27th, 2020, Nigeria’s President, Muhammadu Buhari declared an overnight curfew from 8 pm to 6 am across the country, as part of new measures to contain the spread of the COVID-19. This comes along with the phased and gradual easing of lockdown measures in FCT, Lagos, and Ogun States, which took effect from Saturday, 2nd May 2020, at 9 am.
On Monday, 29th June 2020 the federal government extended the second phase of the eased lockdown by 4 weeks and approved interstate movement outside curfew hours with effect from July 1, 2020. Also, on Monday 27th July 2020, the federal government extended the second phase of eased lockdown by an additional one week.
On Thursday, 6th August 2020 the federal government through the secretary to the Government of the Federation (SGF) and Chairman of the Presidential Task Force (PTF) on COVID-19 announced the extension of the second phase of eased lockdown by another four (4) weeks.
Covid-19: UK to approve Pfizer, BioTNech vaccine, to start immunization December 7
The UK government is set to approve the COVID-19 vaccine developed by BioNTech SE and Pfizer Inc next week.
The global reception of the Covid-19 vaccine developed by Pfizer Inc in collaboration with BioNTech following the positive outcome of its phase 3 trial, seems to have intensified as it is set for approval by the UK medical regulator.
According to Reuters, a report from Financial Times on Saturday suggests that deliveries would commence within hours of the authorization with the first immunizations using the BioNTech and Pfizer vaccine possibly taking place from December 7.
The UK Prime Minister, Boris Johnson, had earlier in the day, named Nadhim Zahawi, who is the current junior business minister, as the minister responsible for the deployment of COVID-19 vaccines.
The UK government has placed an order for 40 million doses of the Pfizer and BioNTech vaccine, which has been found to be 95% effective in the final analysis of the phase 3 trials in preventing the spread of a virus that has killed over 1.4 million people across the world with its devastating impact on the global economy.
The UK government had on November 20, formally asked its medical regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), to conduct a study of the Pfizer-BioNTech COVID-19 vaccine with a view to determining its suitability, the first step in making it available outside the United State
The government which had secured 100 million doses of the Covid-19 vaccine developed by AstraZeneca and University of Oxford had also asked the regulator on Friday to assess the vaccine for a possible rollout before Christmas.
What you should know: The US drugmaker, Pfizer Inc, on November 18, 2020, announced that a final analysis of clinical-trial data of its experimental Covid-19 vaccine, which it is developing in collaboration with BioTNech, showed it was 95% effective, thereby paving the way for the company to apply for the first U.S. regulatory authorization for a coronavirus shot.
Pfizer said they had no serious safety concerns in a trial that involves almost 44,000 participants as their vaccine protected people of all ages and ethnicities.
It’s highly speculative to deny the coronavirus started in China – WHO
The WHO has stated that it can not categorically say that the coronavirus disease did not emanate from China, where reports first emerged.
The World Health Organization (WHO) has stated that it would be highly speculative for the UN health agency to say that the coronavirus disease did not emanate from China, where it was first identified in a food market in December 2019.
According to a report from Reuters, this statement was made by WHO’s Executive Director, Mike Ryan, at a virtual briefing in Geneva, on Friday, November 27, 2020, after he was asked if the coronavirus disease could have emerged outside China.
China, which has tried to dispel the idea that the virus first originated in the country, is pushing a narrative through state media that the virus existed abroad before it was discovered in the central city of Wuhan, citing the presence of coronavirus on imported frozen food packaging and scientific papers.
It claimed that it had been circulating in Europe last year before it was later discovered in China.
Mike Ryan, at the briefing, said, “I think it’s highly speculative for us to say that the disease did not emerge in China. It is clear from a public health perspective that you start your investigations where the human cases first emerged. Evidence might then lead to other places.”
He still emphasized that the WHO intended to send researchers to the Wuhan food market to probe the virus’s origins further.
What you should know
In the wake of the outbreak of the coronavirus pandemic, the World Health Organization had constituted a team of experts to travel to China and work with their Chinese counterparts to identify the source of the virus.
The US government has been very critical of WHO as regards its handling of the health crisis, accusing them of being complicit and colluding with China in the mismanagement of the coronavirus pandemic.